Detalles de la búsqueda
1.
Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor.
Cancer Discov
; 12(6): 1482-1499, 2022 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35254416
2.
2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback (Part 2A - Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation Part 2B - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine).
Bioanalysis
; 13(5): 295-361, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33511867
3.
[Stress or "professional folly"?]. / Stress oder "geschäftige Torheit"?
Krankenpfl Soins Infirm
; 108(12): 28-9, 2015.
Artículo
en Alemán
| MEDLINE | ID: mdl-26775418
4.
A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted Activity.
Front Oncol
; 10: 598477, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33425754
5.
2019 White Paper on Recent Issues in Bioanalysis: Chromatographic Assays (Part 1 - Innovation in Small Molecules and Oligonucleotides & Mass Spectrometric Method Development Strategies for Large Molecule Bioanalysis).
Bioanalysis
; 11(22): 2029-2048, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31808716
6.
2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity).
Bioanalysis
; 10(23): 1897-1917, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30488729
7.
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 - Hybrid LBA/LCMS and input from regulatory agencies).
Bioanalysis
; 8(23): 2457-2474, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27855509
8.
A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated Cytotoxicity.
AAPS J
; 17(6): 1417-26, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26205082
9.
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 - hybrid LBA/LCMS and input from regulatory agencies).
Bioanalysis
; 7(23): 3019-34, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26627049
10.
Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants.
J Immunol Methods
; 291(1-2): 27-38, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15345302
11.
Effects of glycoprotein IIb/IIIa antagonists on platelet activation: development of a transfer method to mimic peak to trough receptor occupancy.
Thromb Res
; 107(6): 303-17, 2002 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12565717
12.
Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays.
J Pharm Biomed Anal
; 74: 235-45, 2013 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23245256
13.
Ligand binding assays in the 21st Century laboratory: automation.
AAPS J
; 14(1): 142-53, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22302584
14.
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.
Blood
; 99(10): 3540-6, 2002 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11986205
Resultados
1 -
14
de 14
1
Próxima >
>>